Chemotherapy combined with pembrolizumab in advanced gallbladder cancer with subsequent radical resection: A case report.
Gallbladder cancer is often diagnosed at an advanced stage, preventing radical surgical intervention.
APA
Hu Y, Wei Y, et al. (2026). Chemotherapy combined with pembrolizumab in advanced gallbladder cancer with subsequent radical resection: A case report.. iLIVER, 5(1), 100219. https://doi.org/10.1016/j.iliver.2026.100219
MLA
Hu Y, et al.. "Chemotherapy combined with pembrolizumab in advanced gallbladder cancer with subsequent radical resection: A case report.." iLIVER, vol. 5, no. 1, 2026, pp. 100219.
PMID
41647477
Abstract
Gallbladder cancer is often diagnosed at an advanced stage, preventing radical surgical intervention. Combined with its highly aggressive nature, this results in a generally poor prognosis. Although advancements in treatment strategies have expanded the application of conversion therapy for initially unresectable gallbladder cancer cases, achieving eligibility for radical resection remains uncommon. Here, we report a case of advanced gallbladder cancer where treatment with pembrolizumab combined with gemcitabine and cisplatin was followed by successful radical surgical resection, demonstrating a favorable therapeutic outcome. This case highlights the potential of combining immunotherapy and chemotherapy for improving treatment responses and surgical outcomes in advanced gallbladder cancer.
같은 제1저자의 인용 많은 논문 (5)
- Supramastoid Fascia as an Autologous Donor Site Alternative for Moderate Dorsal Augmentation: A Multicenter Prospective Study.
- ICAP-1 alternative splicing regulates Talin tension polarization in NSCLC durotaxis.
- Fgfr4 combined with inflammatory cytokines improves recurrence risk prediction in differentiated thyroid carcinoma: A retrospective cohort study.
- Thorough analysis of tumor microenvironment, prognostic model, and immunotherapy prediction in hepatocellular carcinoma based on vascular normalization-related genes.
- Pretreatment multiphasic contrast-enhanced CT predicts tumor regression grade and survival in locally advanced gastric cancer.